|
|
|
April 30, 2007
Hansen Medical Enters Joint Development and Co-Marketing Agreement with St. Jude Medical
Hansen Medical was founded by Fred Moll, founder of Intuitive Surgical and Senior Advisor at Kearny Venture Partners. Hansen represents Fred's fourth successful entrepreneurial venture. Fred and his team have developed a robotically-controlled catheter to perform minimally invasive procedures, beginning with intracardiac ablation for atrial fibrillation. KVP partner Jim Shapiro serves on the board of Hansen. Below, Hansen reports entering a joint development and co-marketing deal agreement with St. Jude Medical.
--------------------------------
Hansen Medical today announced it has entered into joint
development and co-marketing agreements with St. Jude
Medical of St. Paul, Minn., a global leader of electrophysiology
(EP) technology, to integrate technologies from its Sensei(TM)
Robotic Catheter System and Artisan(TM) Control Catheter
with St. Jude Medical's EnSite(TM) System.
The EnSite system is a computer-based technology marketed
worldwide that facilitates EP procedures by creating real-time
3D graphical displays or maps of cardiac structures and
arrhythmias. These maps are designed to provide the visual
guidance necessary to navigate catheters used during EP
procedures. Previously, two dimensional technologies such
as fluoroscopy or ultrasound were used to assist physicians
with guiding catheters inside the heart, which is a three-dimensional
space. Combining the Sensei and EnSite technologies is
intended to provide physicians with 3D visualization that
will augment their ability to confidently move a catheter
throughout the heart, as well as greatly increase control
over placement of the catheter in specific locations.
"This joint development agreement facilitates an
advanced level of integration of the Sensei system with
one of the market-leading 3D mapping technologies for
EP," said Frederic Moll, M.D., founder and chief
executive officer of Hansen Medical. "Integration
of the Artisan catheter within the EnSite System's 3D
map will give physicians the ability to move the catheter
deliberately and accurately while seeing specifically,
in three dimensions, the location of the catheter inside
the heart. This is an important step toward achieving
automation of EP procedures, which we believe is key to
providing clinicians of varying skill levels the ability
to more effectively and safely treat complex cardiac arrhythmias."
Back to News
|
|
| |
